Yahoo Finance • 11 days ago
PONTE VEDRA, Fla., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the gaps in anticoagulation therapy, today announced that it... Full story
Yahoo Finance • 2 months ago
* Cadrenal Therapeutics press release [https://seekingalpha.com/pr/20195890-cadrenal-therapeutics-reports-second-quarter-2025-financial-results-and-provides-corporate] (NASDAQ:CVKD [https://seekingalpha.com/symbol/CVKD]): Q2 GAAP EPS of... Full story
Yahoo Finance • 3 months ago
Cadrenal Therapeutics , Inc. (NASDAQ:CVKD), a micro-cap biotech company with a market capitalization of $23.34 million, announced that Robert Lisicki has resigned from its board of directors, effective immediately, according to a statement... Full story